BioMarin Pharmaceutical Inc. (BMRN) Thursday said it expects fiscal year 2009 GAAP loss in the range of $8.0 million to $4.0 million. Non-GAAP net income is forecast in the range of $39.8 million to $43.8 million. Total net product revenues are forecast in the range of $306 million to $320 million.
Street analysts expect a loss of $0.04 per share on revenues of $323.04 million.
For the fiscal year 2010, the company expects GAAP net income in the range of $2 million to $12 million. Non-GAAP net income is expected to range from $39 million to $49 million. Total net product revenues for the year are forecast to range from $368 million to $398 million.
Street analysts expect earnings of $0.23 per share on revenues of $398.27 million.
For comments and feedback: editorial@rttnews.com